TRIAMCINOLONE ACET 200 MG/5 ML
TRIAMCINOLONE ACETATE 200 MG/5 ML, a generic anti-inflammatory steroid, has a $3.99 acquisition cost while hospitals typically charge 8-15 times this amount for the same medication.
About the analyst
Kevin Nyk analyzes hospital pricing data at BillRazor Research. He specializes in Medicare reimbursement patterns and chargemaster pricing across U.S. hospitals. Expertise: hospital pricing, Medicare rates, chargemaster analysis.
Triamcinolone acetonide is a corticosteroid anti-inflammatory medication commonly prescribed for conditions like arthritis, allergic reactions, and inflammatory disorders. This generic formulation typically generates lower reimbursement rates compared to brand-name alternatives, with Medicare coverage varying based on the specific indication and administration route documented.
No credit card required. Results in 60 seconds.
Related pricing data
Data source: National Average Drug Acquisition Cost (NADAC) survey, published by CMS. HCPCS drug pricing codes from Medicare Part B Drug Average Sales Price file.
What NADAC means: The average price pharmacies pay to acquire this drug from wholesalers. Hospital charges for the same drug are typically higher due to facility fees, compounding, and administration costs.
Limitations: NADAC reflects pharmacy acquisition cost, not patient out-of-pocket cost. Insurance copays, formulary tiers, and manufacturer rebates affect what patients actually pay.